{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T07:58:41Z","timestamp":1787644721598,"version":"build-2736575974"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2022,4,23]],"date-time":"2022-04-23T00:00:00Z","timestamp":1650672000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,4,23]],"date-time":"2022-04-23T00:00:00Z","timestamp":1650672000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"State Administration of Traditional Chinese Medicine Industry Specialty","award":["201407001-4"],"award-info":[{"award-number":["201407001-4"]}]},{"DOI":"10.13039\/501100014207","name":"National Public Health Grand Research Foundation","doi-asserted-by":"crossref","award":["201202017"],"award-info":[{"award-number":["201202017"]}],"id":[{"id":"10.13039\/501100014207","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Priority Academic Program Development of Jiangsu Higher Education Institute","award":["JX10231801"],"award-info":[{"award-number":["JX10231801"]}]},{"name":"Jiangsu Provincial Special Program of Medical Science","award":["BL201408"],"award-info":[{"award-number":["BL201408"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1007\/s00277-022-04847-2","type":"journal-article","created":{"date-parts":[[2022,4,23]],"date-time":"2022-04-23T10:02:42Z","timestamp":1650708162000},"page":"1493-1498","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Clinical characteristics and outcomes of 100 adult patients with pure red cell aplasia"],"prefix":"10.1007","volume":"101","author":[{"given":"Xuemei","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lang","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingzong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3944-5897","authenticated-orcid":false,"given":"Guangsheng","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianyong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,4,23]]},"reference":[{"issue":"21","key":"4847_CR1","doi-asserted-by":"publisher","first-page":"2504","DOI":"10.1182\/blood-2016-05-717140","volume":"128","author":"RT Means","year":"2016","unstructured":"Means RT (2016) Pure red cell aplasia. Blood 128(21):2504\u20132509. https:\/\/doi.org\/10.1182\/blood-2016-05-717140","journal-title":"Blood"},{"issue":"7","key":"4847_CR2","doi-asserted-by":"publisher","first-page":"3000","DOI":"10.1182\/blood.V87.7.3000.bloodjournal8773000","volume":"87","author":"M Lacy","year":"1996","unstructured":"Lacy M (1996) Pure red cell aplasia\u202f: association with large granular lymphocyte leukemia and the prognostic value of cytogenetic abnormalities. Blood 87(7):3000","journal-title":"Blood"},{"issue":"4","key":"4847_CR3","first-page":"275","volume":"28","author":"E Dessypris","year":"1991","unstructured":"Dessypris E (1991) The biology of pure red cell aplasia. Semin Hematol 28(4):275\u2013284","journal-title":"Semin Hematol"},{"issue":"3","key":"4847_CR4","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1111\/j.1365-2141.2006.06295.x","volume":"135","author":"CA Thompson","year":"2006","unstructured":"Thompson CA, Steensma DP (2006) Pure red cell aplasia associated with thymoma: clinical insights from a 50-year single-institution experience. Br J Haematol 135(3):405\u2013407. https:\/\/doi.org\/10.1111\/j.1365-2141.2006.06295.x","journal-title":"Br J Haematol"},{"issue":"12","key":"4847_CR5","doi-asserted-by":"publisher","first-page":"3995","DOI":"10.1182\/blood.v97.12.3995","volume":"97","author":"M Zecca","year":"2001","unstructured":"Zecca M, Stefano PD, Nobili B, Locatelli F (2001) Anti-CD20 monoclonal antibody for the treatment of severe, immune-mediated, pure red cell aplasia and hemolytic anemia. Blood 97(12):3995\u20133997. https:\/\/doi.org\/10.1182\/blood.v97.12.3995","journal-title":"Blood"},{"issue":"5","key":"4847_CR6","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1111\/j.1365-2141.2009.08027.x","volume":"148","author":"AM Risitano","year":"2010","unstructured":"Risitano AM, Selleri C, Serio B, Torelli GF, Kulagin A, Maury S, Halter J, Gupta V, Bacigalupo A, Soci\u00e8 G, Tichelli A, Schrezenmeier H, Marsh J, Passweg J, Rotoli B, on behalf of the Working Party Severe Aplastic Anaemia (WPSAA) of the European Group for Blood and Marrow Transplantation (EBMT) (2010) Alemtuzumab is safe and effective as immunosuppressive treatment for aplastic anaemia and single-lineage marrow failure: a pilot study and a survey from the EBMT WPSAA. Br J Haematol 148(5):791\u2013796. https:\/\/doi.org\/10.1111\/j.1365-2141.2009.08027.x","journal-title":"Br J Haematol"},{"issue":"3","key":"4847_CR7","doi-asserted-by":"publisher","first-page":"382","DOI":"10.3324\/haematol.2009.013557","volume":"95","author":"EM Sloand","year":"2010","unstructured":"Sloand EM, Olnes MJ, Weinstein B, Wu C, Maciejewski J, Scheinberg P, Young NS (2010) Long-term follow-up of patients with moderate aplastic anemia and pure red cell aplasia treated with daclizumab. Haematologica 95(3):382\u2013387. https:\/\/doi.org\/10.3324\/haematol.2009.013557","journal-title":"Haematologica"},{"issue":"14","key":"4847_CR8","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1177\/0961203311411349","volume":"20","author":"R Gupta","year":"2011","unstructured":"Gupta R, Ezeonyeji A, Thomas A, Scully M, Ehrenstein M, Isenberg D (2011) A case of pure red cell aplasia and immune thrombocytopenia complicating systemic lupus erythematosus: Responseto rituximab and cyclophosphamide. Lupus 20(14):1547\u20131550. https:\/\/doi.org\/10.1177\/0961203311411349","journal-title":"Lupus"},{"issue":"3","key":"4847_CR9","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1038\/leu.2010.278","volume":"25","author":"J Rossignol","year":"2010","unstructured":"Rossignol J, Michallet AS, Oberic L, Picard M, Garon A, Willekens C, Dulery R, Leleu X, Cazin B, Ysebaert L (2010) Rituximab-cyclophosphamide-dexamethasone combination in the management of autoimmune cytopenias associated with chronic lymphocytic leukemia. Leukemia 25(3):473\u2013478. https:\/\/doi.org\/10.1038\/leu.2010.278","journal-title":"Leukemia"},{"issue":"8","key":"4847_CR10","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.3324\/haematol.11192","volume":"92","author":"K Sawada","year":"2007","unstructured":"Sawada K, Hirokawa M, Fujishima N, TeramuraM Bessho M, Dan K, Tsurumi H, Nakao S, Urabe A, Omine M, Ozawa K, PRCA Collaborative Study Group (2007) Long-term outcome of patients with acquired primary idiopathic pure red cell aplasia receiving cyclosporine A. A nationwide cohort study in Japan for the PRCA Collaborative Study Group. Haematologica 92(8):1021\u20131028. https:\/\/doi.org\/10.3324\/haematol.11192","journal-title":"Haematologica"},{"issue":"2","key":"4847_CR11","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s12185-018-2446-y","volume":"108","author":"X Wu","year":"2018","unstructured":"Wu X, Wang S, Lu X, Shen W, Qiao C, Wu Y, Lu R, Wang S, Zhang J, Hong M, Zhu Y, Li J, He G (2018) Response to cyclosporine A and corticosteroids in adult patients with acquired pure red cell aplasia: serial experience at a single center. Int J Hematol 108(2):123\u2013129. https:\/\/doi.org\/10.1007\/s12185-018-2446-y","journal-title":"Int J Hematol"},{"issue":"1","key":"4847_CR12","doi-asserted-by":"publisher","first-page":"27","DOI":"10.3324\/haematol.11655","volume":"93","author":"M Hirokawa","year":"2008","unstructured":"Hirokawa M, Sawada K, Fujishima N, Nakao S, Urabe A, Dan K, Fujisawa S, Yonemura Y, Kawano F, Omine M, Ozawa K, PRCA Collaborative Study Group (2008) Long-term response and outcome following immunosuppressive therapy in thymoma associated pure red cell aplasia: a nationwide cohort study in Japan by the PRCA collaborative study group. Haematologica 93(1):27\u201333. https:\/\/doi.org\/10.3324\/haematol.11655","journal-title":"Haematologica"},{"key":"4847_CR13","first-page":"348","volume-title":"WHO Classification of tumours of haematopoietic and lymphoid tissues","author":"SH Swerdlow","year":"2017","unstructured":"Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H et al (2017) WHO Classification of tumours of haematopoietic and lymphoid tissues, Revised 4th. IARC, Lyon, pp 348\u2013354","edition":"Revised 4th"},{"issue":"9","key":"4847_CR14","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1182\/blood-2016-08-692590","volume":"129","author":"T Lamy","year":"2017","unstructured":"Lamy T, Moignet A, Loughran TP Jr (2017) LGL leukemia: from pathogenesis to treatment. Blood 129(9):1082\u20131094. https:\/\/doi.org\/10.1182\/blood-2016-08-692590","journal-title":"Blood"},{"issue":"15","key":"4847_CR15","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.1182\/blood.2021010898","volume":"137","author":"C Gurnari","year":"2021","unstructured":"Gurnari C, Maciejewski JP (2021) How I manage acquired pure red cell aplasia in adults. Blood 137(15):2001\u20132009. https:\/\/doi.org\/10.1182\/blood.2021010898","journal-title":"Blood"},{"key":"4847_CR16","unstructured":"Mangla A, Hamad H (2022) Pure Red Cell Aplasia. In: StatPearls. StatPearls Publishing, Treasure Island"},{"issue":"6","key":"4847_CR17","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1111\/bjh.13376","volume":"169","author":"M Hirokawa","year":"2015","unstructured":"Hirokawa M, Sawada K, Fujishima N, Teramura M, Bessho M, Dan K, Tsurumi H, Nakao S, Urabe A, Fujisawa S, Yonemura Y, Kawano F, Oshimi K, Sugimoto K, Matsuda A, Karasawa M, Arai A, Komatsu N, Harigae H, Omine M, Ozawa K, Kurokawa M, for the PRCA Collaborative Study Group (2015) Long-term outcome of patients with acquired chronic pure red cell aplasia (PRCA) following immunosuppressive therapy: a final report of the nationwide cohort study in 2004\/2006 by the Japan PRCA collaborative study group. Br J Haematol 169(6):879\u2013886. https:\/\/doi.org\/10.1111\/bjh.13376","journal-title":"Br J Haematol"},{"issue":"4","key":"4847_CR18","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1111\/j.1600-0609.2009.01213.x","volume":"82","author":"S Kawahara","year":"2009","unstructured":"Kawahara S, Sasaki M, Isobe Y, Ando J, Noguchi M, Koike M, Hirano T, Oshimi K, Sugimoto K (2009) Clinical analysis of 52 patients with granular lymphocyte proliferative disorder (GLPD) showed frequent anemia in indolent T-cell GLPD in Japan. Eur J Haematol 82(4):308\u2013314. https:\/\/doi.org\/10.1111\/j.1600-0609.2009.01213.x","journal-title":"Eur J Haematol"},{"issue":"4","key":"4847_CR19","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1007\/s00277-009-0895-3","volume":"89","author":"YL Kwong","year":"2010","unstructured":"Kwong YL, Au WY, Leung AY, Tse EW (2010) T-cell large granular lymphocyte leukemia: an Asian perspective. Ann Hematol 89(4):331\u2013339. https:\/\/doi.org\/10.1007\/s00277-009-0895-3","journal-title":"Ann Hematol"},{"issue":"1","key":"4847_CR20","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/1756-8722-6-82","volume":"6","author":"ZY Qiu","year":"2013","unstructured":"Qiu ZY, Fan L, Wang L, Qiao C, Wu YJ, Zhou JF (2013) Xu W and Li JY (2006) STAT3 mutations are frequent in T-cell large granular lymphocytic leukemia with pure red cell aplasia. J Hematol Oncol 6(1):82. https:\/\/doi.org\/10.1186\/1756-8722-6-82","journal-title":"J Hematol Oncol"},{"issue":"5","key":"4847_CR21","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.blre.2006.01.003","volume":"20","author":"EJ Burks","year":"2006","unstructured":"Burks EJ, Loughran TP (2006) Pathogenesis of neutropenia in large granular lymphocyte leukemia and Felty syndrome. Blood Rev 20(5):245\u2013266. https:\/\/doi.org\/10.1016\/j.blre.2006.01.003","journal-title":"Blood Rev"},{"issue":"3","key":"4847_CR22","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1007\/s00277-020-03926-6","volume":"99","author":"X Liu","year":"2020","unstructured":"Liu X, Lu X, Chen L, Yang Y, Wu X, Lu R, Wang S, Zhang J, Hong M, Zhu Y, He G, Li J (2020) Immunosuppressive therapy for elderly-acquired pure red cell aplasia: cyclosporine A may be more effective. Ann Hematol 99(3):443\u2013449. https:\/\/doi.org\/10.1007\/s00277-020-03926-6","journal-title":"Ann Hematol"},{"issue":"7","key":"4847_CR23","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1002\/ajh.26183","volume":"96","author":"N Dong","year":"2021","unstructured":"Dong N, Castillo Tokumori F, Isenalumhe L, Zhang Y, Tandon A, Knepper TC, Mo Q, Shao H, Zhang L, Sokol L (2021) Large granular lymphocytic leukemia\u2013A retrospective study of 319 cases. Am J Hematol 96(7):772\u2013780. https:\/\/doi.org\/10.1002\/ajh.26183","journal-title":"Am J Hematol"},{"issue":"10","key":"4847_CR24","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.3324\/haematol.12871","volume":"93","author":"N Fujishima","year":"2008","unstructured":"Fujishima N, Sawada K, Hirokawa M, Oshimi K, Sugimoto K, Matsuda A, Teramura M, Karasawa M, Arai A, Yonemura Y, Nakao S, Urabe A, Omine M, Ozawa K, PRCA Collaborative Study Group (2008) Long-term responses and outcomes following immunosuppressive therapy in large granular lymphocyte leukemia-associated pure red cell aplasia: a Nationwide Cohort Study in Japan for the PRCA Collaborative Study Group. Haematologica 93(10):1555\u20131559. https:\/\/doi.org\/10.3324\/haematol.12871","journal-title":"Haematologica"},{"issue":"3","key":"4847_CR25","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1111\/cas.12341","volume":"105","author":"F Ishida","year":"2014","unstructured":"Ishida F, Matsuda K, Sekiguchi N, Makishima H, Taira C, Momose K, Nishina S, Senoo N, Sakai H, Ito T, Kwong YL (2014) STAT3 gene mutations and their association with pure red cell aplasia in large granular lymphocyte Leukemia. Cancer Sci 105(3):342\u2013346. https:\/\/doi.org\/10.1111\/cas.12341","journal-title":"Cancer Sci"},{"issue":"1","key":"4847_CR26","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1007\/s12185-021-03100-2","volume":"114","author":"X Liu","year":"2021","unstructured":"Liu X, Cheng L, He Y, Zhang R, Lu R, Zhang J, Hong M, He G, Li J (2021) Eltrombopag restores erythropoiesis in refractory adult acquired pure red cell aplasia. Int J Hematol 114(1):124\u2013128. https:\/\/doi.org\/10.1007\/s12185-021-03100-2","journal-title":"Int J Hematol"},{"issue":"6","key":"4847_CR27","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1111\/bjh.15245","volume":"184","author":"H Jiang","year":"2019","unstructured":"Jiang H, Zhang H, Wang H, Qi W, Cao Q, Xing L, Fu R, Shao Z, Wang H (2019) Sirolimus for the treatment of multi-resistant pure red cell Aplasia. Br J Haematol 184(6):1055\u20131058. https:\/\/doi.org\/10.1111\/bjh.15245","journal-title":"Br J Haematol"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-022-04847-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-022-04847-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-022-04847-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,16]],"date-time":"2022-06-16T09:05:36Z","timestamp":1655370336000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-022-04847-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,23]]},"references-count":27,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["4847"],"URL":"https:\/\/doi.org\/10.1007\/s00277-022-04847-2","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,23]]},"assertion":[{"value":"21 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was performed in accordance with the Declaration of Helsinki and Good Clinical Practice guidelines. All patients or legal guardians provided written informed consent authorizing the use of their personal information for research purposes.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors give their consent to publish this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that there are no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}